Article Correctness Is Author's Responsibility: Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

The article below may contain offensive and/or incorrect content.

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.